HAX’s VC-Founder Industry Hard Tech Matchup is now accepting applications. Register today!

BryoSphere Biotechnologies

Sustainable specialty chemical manufacturing using engineered moss


Hila Behar

CEO & Co-Founder

Liz Mahon

Co-Founder & CSO

Company details

BryoSphere Biotechnologies uses moss plants and biotechnology techniques to synthesize rare, plant-derived specialty compounds. By harnessing the genetic information of a variety of plants, BryoSphere achieves the production of rare compounds with significantly higher yields compared to those found in their natural counterparts, thereby enhancing accessibility. Currently, BryoSphere is dedicated to the development of two key products: one for addressing skin hyperpigmentation in topical treatments, and another as an anti-cancer drug.

Get In Touch with BryoSphere Biotechnologies

Please tell us a little bit about yourself and why you'd like to get connected. BryoSphere Biotechnologies + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.